期刊文献+

参仙升脉口服液联合阿托品治疗心动过缓性心律失常疗效观察 被引量:3

Effect observation of Senxianshengmai oral liquid oral liquid and atropine in treatment of bradycardia arrhythmias
原文传递
导出
摘要 目的观察中西医结合疗法治疗缓慢性心律失常的疗效及应用价值。方法随机将58例缓慢心律失常患者分为治疗组及对照组,对照组29例给予西医治疗,口服阿托品0.3mg,3次/d治疗。治疗组29例在采用阿托品治疗基础上加用参仙升脉口服液,每次20ml口服,2次/d。疗程2周。结果治疗组显效7例,有效17例,无效5例,总有效率92.6%;对照组显效3例,有效13例,无效13例,总有效55%。两组差别有统计学意义(P<0.01);体表心电图和24h动态心电图,治疗组和对照组总有效率分别为90%和41%,24h心率总数分别是(89 420±4 800)次和(63 250±3 700)次,两组差异有统计学意义(P<0.01)。结论中西医结合治疗缓慢性心律失常的疗效优于纯西药治疗。可使部分患者免于安装起搏器,值得临床推广。 Objective To observe the efficacy and value of Integrative treatment of arrhythmia.Methods Totally 58 patients were randomly divided into treatment groups of patients bradyarrhythmia and the control group,control group given western medicine treatment of 29 cases of oral atropine 0.3mg,3 times/day treatment.Besed on atropine the treatment group of 29 cases were added Senxianshengmai oral liquid 20ml orally,2 times/day.2 weeks.Results The treatment group obvious effective 7 cases,effective in 17 cases,5 cases ineffective,the total effective rate was 92.6%;Control group 3 cases were markedly,effective in 13 cases,ineffective in 13 cases,55% of the total effective rate.Difference between the two groups was significant(P0.01);Surface ECG and 24-hour ambulatory ECG,the treatment group and control group,the total effective rate was 90% and 41%,the total number of 24-hour heart rate were(89420±4800)time and(63250±3700)times,the difference was significant(P0.01).Conclusions Integrative Medicine bradycardia effective than western medicine.Some patients can be free from pacemaker and is worthy of promotion.
作者 郭晓丽
出处 《医药论坛杂志》 2011年第3期128-129,共2页 Journal of Medical Forum
关键词 中西医结合 缓慢性心律失常 参仙升脉口服液 Integrative medicine Arrhythmia Senxianshengmai oral liquid
  • 相关文献

参考文献3

二级参考文献1

  • 1叶任高.内科学(第5版)[M].北京:人民卫生出版社,2000.159.

共引文献356

同被引文献50

  • 1黄宛.临床心电学.北京:人民卫生出版社,1998:419-421.
  • 2孟庆仪.常见心律失常严重程度及疗效参考标准,/临床心电学的新概念.北京:科学技术文献出版社,1998:55-57.
  • 3I-Iiggins JPT,Green S.Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration,2011.Available from www.cochrane- handbook.org.
  • 4Higgins J P T, Altman DG,Steme J A C.Chapter 8:Assessing risk of bias in included studies.In:Higgins JPT,Green S,editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011).The Cochrane Collaboration, 2011.Available from www.cochrane-handbook.org.
  • 5Review Manager(RevMan)[Computer program].Version5.3. Copenhagen:The Nordic Cochrane Centre,The Cochrane Collaboration,2014.
  • 6武建伟,田梅.参仙升脉口服液治疗缓慢性心律失常48例.医药导报,2013,32:21.
  • 7北京中医药大学.治疗缓慢性心律失常的新药--参仙升脉口服液.中国药学杂志,2010,36(19):640-641.
  • 8赫连胜,徐维.参仙升脉口服液与环磷腺苷葡胺治疗心动过缓的疗效观察[J].中国当代医药,2009,16(24):69-70. 被引量:4
  • 9刘锦涛,李应东.中西医结合治疗心动过缓性心律失常疗效观察[J].中国社区医师(医学专业),2010,12(10):76-76. 被引量:4
  • 10韩伟,耿乃志.参仙升脉口服液治疗缓慢性心律失常的临床观察[J].黑龙江中医药,2010,39(4):11-12. 被引量:9

引证文献3

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部